Literature DB >> 9704009

Cre-loxP-mediated DNA flip-flop in mammalian cells leading to alternate expression of retrovirally transduced genes.

M Kano1, H Igarashi, I Saito, M Masuda.   

Abstract

While DNA excision by Cre-loxP homologous recombination has been exploited for mammalian genetic engineering, it has not been reported whether DNA inversion is achievable by the same mechanism in mammalian cells. To investigate whether Cre-loxP-mediated DNA inversion takes place in mammalian cells, a novel retroviral vector, NT(FF), was constructed. The vector carries a marker gene cassette consisting of the neo and tk genes linked tail-to-tail to each other and flanked by an inverted repeat of loxP sequences. In NT(FF)-transduced Rat2 cells, the marker gene cassette was inverted reversibly in a Cre-dependent manner, leading to DNA "flip-flop" associated with alternate expression of the neo and tk genes. This study provides the first example of Cre-loxP-mediated DNA inversion in mammalian cells facilitating regulation of retrovirally transduced genes, suggesting the usefulness of the system for genetic engineering.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704009     DOI: 10.1006/bbrc.1998.9011

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Adopting the good reFLEXes when generating conditional alterations in the mouse genome.

Authors:  Frank Schnütgen; Norbert B Ghyselinck
Journal:  Transgenic Res       Date:  2007-04-06       Impact factor: 2.788

2.  A system for Cre-regulated RNA interference in vivo.

Authors:  Patrick Stern; Sophie Astrof; Stefan J Erkeland; Joshua Schustak; Phillip A Sharp; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

3.  Strict control of telomerase activation using Cre-mediated inversion.

Authors:  Mark D Ungrin; Lea Harrington
Journal:  BMC Biotechnol       Date:  2006-02-20       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.